Mastocytosis

For patient information, click here

Diagnosis
History & Symptoms | Physical Examination | Staging | Lab Tests | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention

Additional Resources

 * Based on an informative page by the National Institute of Allergy and Infectious Diseases (NIAID).
 * Shah NP, Lee FJ, Luo R, Jiang Y, Donker M, Akin C. Dasatinib (BMS-354825) inhibits KIT(D816V), an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis. Blood. 2006; 108(1):286-291. PMID 16434489.
 * Pardanani A, Teffer A. Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature. Current Opinion in Hematology. 2010; 17(2): 125-132. PMID 20075725.

Resources

 * Mastocytosis Society, Inc.
 * Mastocytosis email lists
 * Mastokids.org
 * UK Mastocytosis support

Mastozytose Mastocitosis Mastocytose Mastocytose